Ultrasound vs MRI for measuring liver fat in MASLD
Part of Digestive system clinical trials.
This study compares ultrasound (DeepUSFF) and MRI (MRI-PDFF) for measuring liver fat in people with MASLD (a type of fatty liver disease not caused by alcohol). It aims to see if ultrasound can be used as a cheaper, more accessible alternative to MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have suspected MASLD (fatty liver disease not from alcohol) based on abnormal ultrasound or liver blood tests.
- You have a BMI of 25 or higher, or a waistline over 90 cm (men) or 80 cm (women).
- You have no other liver diseases (like hepatitis B or C, cirrhosis, or liver cancer).
- You have not had more than a moderate amount of alcohol almost every day in the past 2 years (men: over about 2 drinks daily, women: over about 1.5 drinks daily).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
This study uses ultrasound to look at the liver and help classify a type of fatty liver disease called MASLD. It may help doctors better understand and diagnose this condition.
This study compares two ultrasound measurement techniques to see which one better detects and measures fat in the liver. If you have signs of a fatty liver or are being evaluated as a potential organ donor, you may qualify.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study tests a new, non-invasive way to diagnose a type of fatty liver disease (MASLD) in children with obesity. It aims to find simple blood or imaging markers that can detect the condition without a liver biopsy.
This study is testing a new ultrasound method to measure fat in the liver. It is for people who may have a liver condition or have risk factors like diabetes or obesity, as well as healthy volunteers.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.